Prevalence and Phase Variable Expression Status of Two Autotransporters, NalP and MspA, in Carriage and Disease Isolates of Neisseria meningitidis

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Oldfield, Neil J ^a   Matar, Suzan ^a,b   Bidmos, Fadil A ^c   Alamro, Mohammed ^c   Neal, Keith R ^a   Turner, David P J ^a   Bayliss, Christopher D ^a   Ala'Aldeen, Dlawer A A ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF JORDAN   (Jordan)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; PROTEIN MSPA; PROTEIN NALP; UNCLASSIFIED DRUG;

ARTICLE; BACTERIUM CARRIER; BACTERIUM ISOLATE; GENE DELETION; GENE FREQUENCY; HOST PATHOGEN INTERACTION; MENINGOCOCCOSIS; MOLECULAR CLONING; MSPA GENE; NALP GENE; NEISSERIA MENINGITIDIS; NONHUMAN; PHASE VARIABLE EXPRESSION; PHENOTYPE; PREVALENCE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

CARRIER STATE; GENE EXPRESSION REGULATION, BACTERIAL; GENETIC VARIATION; GENOTYPE; HUMANS; MEMBRANE TRANSPORT PROTEINS; MENINGOCOCCAL INFECTIONS; NEISSERIA MENINGITIDIS; PHENOTYPE; POLY C; PORINS; SERINE ENDOPEPTIDASES; SEROTYPING; VIRULENCE;

EID: 84880772418     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0069746     Document Type: Article

References (33)

1. Stephens DS, (2009) Biology and pathogenesis of the evolutionarily successful, obligate human bacterium Neisseria meningitidis. Vaccine 27: B71-77.
2. Caugant DA, Maiden MCJ, (2009) Meningococcal carriage and disease- population biology and evolution. Vaccine 27: B64-B70.
3. Yogev R, Tan T, (2011) Meningococcal disease: The advances and challenges of meningococcal disease prevention. Hum Vaccin 7: 828-837.
4. Gorringe A, Pajón R, (2012) Bexsero: A multicomponent vaccine for prevention of meningococcal disease. Hum Vaccin Immunother 8: 174-183.
5. Vogel U, Taha M-K, Vazquez JA, Findlow J, Claus H, et al. (2013) Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment. Lancet Infect Dis 13: 416-425.
6. Virji M, (2009) Pathogenic neisseriae: surface modulation, pathogenesis and infection control. Nature 7: 274-286.
7. Turner DPJ, Wooldridge KG, Ala'Aldeen DAA (2009) Protein secretion and pathogenesis in Neisseria meningitidis. In: Wooldridge KG, editor. Bacterial secreted proteins: Caister Academic Press. 347-360.
8. Hadi HA, Wooldridge KG, Robinson K, Ala'Aldeen DA, (2001) Identification and characterization of App: an immunogenic autotransporter protein of Neisseria meningitidis. Mol Microbiol 41: 611-623.
9. Ait-Tahar K, Wooldridge KG, Turner DPJ, Atta M, Todd I, et al. (2000) Auto-transporter A protein of Neisseria meningitidis: a potent CD4+ T-cell and B-cell stimulating antigen detected by expression cloning. Mol Microbiol 37: 1094-1105.
10. Turner DPJ, Wooldridge KG, Ala Aldeen DAA, (2002) Autotransported serine protease A of Neisseria meningitidis: an immunogenic, surface-exposed outer membrane, and secreted protein. Infect Immun 70: 4447-4461.
11. Turner DPJ, Marietou AG, Johnston L, Ho KKL, Rogers AJ, et al. (2006) Characterization of MspA, an immunogenic autotransporter protein that mediates adhesion to epithelial and endothelial cells in Neisseria meningitidis. Infect Immun 74: 2957-2964.
12. Leyton DL, Rossiter AE, Henderson IR, (2012) From self sufficiency to dependence: mechanisms and factors important for autotransporter biogenesis. Nat Rev Microbiol 10: 213-225.
13. Benz I, Schmidt MA, (2011) Structures and functions of autotransporter proteins in microbial pathogens. Int J Med Microbiol 301: 461-468.
14. Grijpstra J, Arenas J, Rutten L, Tommassen J (2013) Autotransporter secretion: Varying on a theme. Res Microbiol doi: 10.1016/j.resmic.2013.03.010.
15. van Ulsen P, Adler B, Fassler P, Gilbert M, van Schilfgaarde M, et al. (2006) A novel phase-variable autotransporter serine protease, AusI, of Neisseria meningitidis. Microbes Infect 8: 2088-2097.
16. van Ulsen P, van Alphen L, ten Hove J, Fransen F, van der Ley P, et al. (2003) A Neisserial autotransporter NalP modulating the processing of other autotransporters. Mol Microbiol 50: 1017-1030.
17. Bayliss CD, Palmer ME, (2012) Evolution of simple sequence repeat-mediated phase variation in bacterial genomes. Ann N Y Acad Sci 1267: 39-44.
18. Moxon R, Bayliss CD, Hood DW, (2006) Bacterial contingency loci: the role of simple sequence DNA repeats in bacterial adaptation. Annu Rev Genet 40: 307-333.
19. Bayliss CD, Hoe JC, Makepeace K, Martin P, Hood DW, et al. (2008) Neisseria meningitidis escape from the bactericidal activity of a monoclonal antibody is mediated by phase variation of lgtG and enhanced by a mutator phenotype. Infect Immun 76: 5038-5048.
20. Echenique-Rivera H, Muzzi A, Del Tordello E, Seib KL, Francois P, et al. (2011) Transcriptome analysis of Neisseria meningitidis in human whole blood and mutagenesis studies identify virulence factors involved in blood survival. PLoS Pathog 7: e1002027.
21. Roussel-Jazede V, Jongerius I, Bos MP, Tommassen J, van Ulsen P, (2010) NalP-mediated proteolytic release of lactoferrin-binding protein B from the meningococcal cell surface. Infect Immun 78: 3083-3089.
22. Serruto D, Spadafina T, Ciucchi L, Lewis LA, Ram S, et al. (2010) Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humans. PNAS 107: 3770-3775.
23. Arenas J, Nijland R, Rodriguez F, Bosma T, Tommassen J, (2013) Involvement of three meningococcal surface-exposed proteins, the heparin-binding protein NhbA, the α-peptide of IgA protease, and the autotransporter protease NalP, in initiation of biofilm formation. Mol Microbiol 87: 254-268.
24. Bidmos FA, Neal KR, Oldfield NJ, Turner DPJ, Ala'Aldeen DAA, et al. (2011) Rapid clonal expansion, persistence and clonal replacement of meningococcal carriage isolates in a 2008 university student cohort. J Clin Microbiol 49: 506-512.
25. Tettelin H, Saunders NJ, Heidelberg J, Jeffries AC, Nelson KE, et al. (2000) Complete genome sequence of Neisseria meningitidis serogroup B strain MC58. Science 287: 1809-1815.
26. Harrison OB, Evans NJ, Blair JM, Grimes HS, Tinsley CR, et al. (2009) Epidemiological evidence for the role of the hemoglobin receptor, HmbR, in meningococcal virulence. J Infect Dis 200: 94-98.
27. Tauseef I, Harrison OB, Wooldridge KG, Feavers IM, Neal KR, et al. (2011) Influence of the combination and phase variation status of the haemoglobin receptors HmbR and HpuAB on meningococcal virulence. Microbiology 157: 1446-1456.
28. Claus H, Elias J, Meinhardt C, Frosch M, Vogel U, (2007) Deletion of the meningococcal fetA gene used for antigen sequence typing of invasive and commensal isolates from Germany: Frequencies and mechanisms. J Clin Microbiol 45: 2960-2964.
29. Marsh JW, O'Leary MM, Shutt KA, Harrison LH, (2007) Deletion of fetA gene sequences in serogroup B and C Neisseria meningitidis isolates. J Clin Microbiol 45: 1333-1335.
30. van der Ende A, Hopman CT, Dankert J, (1999) Deletion of porA by recombination between clusters of repetitive extragenic palindromic sequences in Neisseria meningitidis. Infect Immun 67: 2928-2934.
31. Lucidarme J, Comanducci M, Findlow J, Gray SJ, Kaczmarski EB, et al. (2009) Characterization of fHbp, nhbA (gna2132), nadA, porA, sequence type (ST), and genomic presence of IS1301 in group B meningococcal ST269 clonal complex isolates from England and Wales. J Clin Microbiol 47: 3577-3585.
32. Serruto D, Bottomley MJ, Ram S, Giuliani MM, Rappuoli R, (2012) The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: Immunological, functional and structural characterization of the antigens. Vaccine 30Supplement 2: B87-B97.
33. Ladhani SN, Lucidarme J, Newbold LS, Gray SJ, Carr AD, et al. (2012) Invasive meningococcal capsular group Y disease, England and Wales, 2007-2009. Emerg Infect Dis 18: 63-70.